Guangzheng Eye Hospital Group Co., Ltd.

Sümbol: 002524.SZ

SHZ

4.09

CNY

Turuhind täna

-1223.9654
P/E suhe
0.0000
PEG suhe
1.99B
MRK Cap
0.00%
DIV tootlus

Guangzheng Eye Hospital Group Co., Ltd. (002524-SZ) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 644.125 M, mis on 0.160 % gowth. Kogu perioodi keskmine brutokasum on 170.07 M, mis on 0.342 %. Keskmine brutokasumi suhtarv on 0.227 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -1.119 %, mis on võrdne -3.920 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Guangzheng Eye Hospital Group Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus -0.005. Käibevara valdkonnas on 002524.SZ aruandlusvaluutas 316.469. Märkimisväärne osa neist varadest, täpsemalt 91.062, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.392%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 0, kui neid on, aruandlusvaluutas. See näitab erinevust -100.000% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 493.849 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.083%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 283.258 aruandlusvaluutas. Selle aspekti aastane muutus on 0.037%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 190.165, varude hind on 29.62 ja firmaväärtus 377.26, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 39.98. Kontovõlad ja lühiajalised võlad on vastavalt 261.27 ja 383.16. Koguvõlg on 877.01, netovõlg on 785.95. Muud lühiajalised kohustused moodustavad 7.65, mis lisandub kohustuste kogusummale 1263.46. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
balance-sheet.row.cash-and-short-term-investments	307.1	91.1	65.4	89.3	150.8	244.8	413.6	196	125.2	173.6	194.8	469.3	168.8	212	349.5	56.6	37	7.3
balance-sheet.row.short-term-investments	-143.74	0	-68	31	-32	-95.3	120	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	782.74	190.2	143.5	192.1	170.7	223.5	321.6	223.6	196.6	336	354.9	379.2	256.9	241.2	186.1	141.6	63.7	39.6
balance-sheet.row.inventory	151.98	29.6	57.3	53.2	70.7	70	82.4	66.8	53.2	81.8	133.7	132.6	92.4	60.3	47.8	54.8	29.4	10.7
balance-sheet.row.other-current-assets	23.34	5.6	3.3	5.9	8.1	5.1	4.9	19.3	3.2	0.4	-20.9	-36.1	-11.1	-11.6	-11.9	-12.6	-4.5	-1.6
balance-sheet.row.total-current-assets	1265.15	316.5	269.5	340.5	400.3	543.5	822.5	505.6	378.2	591.8	662.5	945.1	506.9	502	571.4	240.4	125.7	56
balance-sheet.row.property-plant-equipment-net	2511.93	619.7	687.6	744.2	314	327.3	739.8	745.2	886.1	907.2	919.2	741.9	286.8	158.2	83.7	69.8	40.3	25.7
balance-sheet.row.goodwill	1511.56	377.3	378.5	517.2	512.2	527.5	621.1	148.4	136.3	144.5	165.5	55.3	0	0	0	0	0	0
balance-sheet.row.intangible-assets	159.62	40	37	55.7	104	145.9	176.7	178.2	196.6	191.6	191.5	147.9	130.3	68.7	29.6	29.5	30	8.6
balance-sheet.row.goodwill-and-intangible-assets	1671.19	417.2	415.5	572.8	616.2	673.4	797.8	326.6	332.9	336.1	357	203.2	130.3	68.7	29.6	29.5	30	8.6
balance-sheet.row.long-term-investments	181.47	0	94	7.2	72.5	152.9	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	182.98	49.7	40.6	40.5	46.4	35.3	53.9	7.6	7.6	6.2	6	6.6	3.7	2.8	1.9	1.9	1.2	0.2
balance-sheet.row.other-non-current-assets	376.81	146.3	50.2	123.6	40.8	43.9	256.4	90.9	15.7	83.7	92.5	95.2	5.3	5.6	5.9	0	0	0.1
balance-sheet.row.total-non-current-assets	4924.38	1232.9	1288	1488.3	1089.9	1232.7	1847.9	1170.2	1242.3	1333.1	1374.6	1046.8	426.2	235.3	121.1	101.3	71.5	34.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	6189.53	1549.4	1557.5	1828.9	1490.2	1776.2	2670.4	1675.8	1620.5	1925	2037.1	1991.9	933.1	737.3	692.6	341.7	197.3	90.7
balance-sheet.row.account-payables	1052.98	261.3	275.5	262.8	256	234.5	383.9	224.8	167.3	260	303.4	263.8	152.4	126.4	105	104.6	41.4	24.8
balance-sheet.row.short-term-debt	1503.14	383.2	360.8	289	200	110.7	421	387.1	356.1	224.4	238	145	150	20	32	60.4	9.7	8
balance-sheet.row.tax-payables	63.8	16	10.9	15.2	14.9	24	83.1	11.8	13.1	12.8	8.8	10.7	7.6	7.6	6.2	0.9	1.6	2.9
balance-sheet.row.long-term-debt-total	2004.97	493.8	448.9	505.7	260	160	315.7	110	184	253.1	269	435	45	50	50	0	0	0
Deferred Revenue Non Current	13.05	0	0	30	4.6	6.5	13.9	17.7	21.5	22.3	21.3	24.3	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	3.33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	29.31	7.7	107.5	10.5	4.1	18.8	360.2	80.4	29.8	33.3	51.1	30.2	17.4	11.2	9.7	14.2	8.7	2.9
balance-sheet.row.total-non-current-liabilities	2047.9	507.6	468.6	507.2	266.2	167.9	329.5	127.7	213.5	295.4	290.3	459.6	63.4	69.6	60.5	9.9	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1693.54	417.3	448.4	475.7	485.3	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	5054.77	1263.5	1282.7	1487.5	1153.3	717.6	1494.7	820	811.7	877.1	999.6	957.1	420.3	247.9	224.7	212	84.2	51.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2068.45	518	515.4	516.4	517.2	515.7	503.3	503.3	503.3	503.3	503.3	503.3	216.9	180.8	90.4	67.8	67.8	20.3
balance-sheet.row.retained-earnings	-1219.92	-299.7	-308.4	-214.1	-247.8	-55.2	-119.5	-44.7	-50.1	-54.6	-61.1	26.6	84.8	63.4	46	29.3	16.5	15.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	200.82	0	46.5	16.6	41.8	67.3	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	74.22	65	19.6	21.6	13.7	360.4	428	306.7	283.4	332.8	324.5	320.4	211.1	245.3	331.5	32.7	28.8	2.8
balance-sheet.row.total-stockholders-equity	1123.57	283.3	273.1	340.6	325	888.2	811.9	765.4	736.6	781.6	766.8	850.3	512.8	489.4	467.9	129.8	113.1	38.9
balance-sheet.row.total-liabilities-and-stockholders-equity	6189.53	1549.4	1557.5	1828.9	1490.2	1776.2	2670.4	1675.8	1620.5	1925	2037.1	1991.9	933.1	737.3	692.6	341.7	197.3	90.7
balance-sheet.row.minority-interest	11.18	2.6	1.7	0.8	11.9	170.3	363.7	90.4	72.1	266.3	270.7	184.4	0	0	0	0	0	0
balance-sheet.row.total-equity	1134.75	285.9	274.8	341.4	336.9	1058.5	1175.6	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	6189.53	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	75.6	19.1	26	38.2	40.5	57.6	120	13.5	13.5	83.4	85.5	85.6	0	0	0	0	0	0
balance-sheet.row.total-debt	3508.11	877	809.7	794.7	460	270.7	736.7	497.1	540.1	477.5	507	580	195	70	82	60.4	9.7	8
balance-sheet.row.net-debt	3201.01	785.9	744.3	736.4	309.2	25.8	323.1	301.2	414.9	304	312.2	110.7	26.2	-142	-267.5	3.8	-27.3	0.7

Rahavoogude aruanne

Guangzheng Eye Hospital Group Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -0.815 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 3.06, mis tähistab 0.505 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -100617737.090. See on -81.893 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 100.02, 0, -232.02, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -11.89 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui 232.16, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
cash-flows.row.net-income	18.29	-77.8	36.4	32.1	157.1	-50.3	7.8	8.1	25.5	-68.3	9.1	27.9	24.3	22.3	19.1	22.4	11.9
cash-flows.row.depreciation-and-amortization	-23.36	100	106.4	62.6	98.4	98	84.2	81.8	77.3	55.1	28.3	14	8.6	6.2	3.3	2.4	1.6
cash-flows.row.deferred-income-tax	-3.08	-2.2	-1.2	-10.9	18.2	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0.15	2.5	6	13.1	10.7	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	0	-108.9	27.9	32.8	-157.3	131.3	48.2	-6.6	19	57.2	-52.6	-29.4	-56.8	-51.7	-20.6	-26	-10.5
cash-flows.row.account-receivables	0	48.7	-23.6	28.8	80.5	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0	-8.7	16.9	-3.9	-4.5	-0.1	-14.8	24.6	46.9	0.5	-37.2	-32	-12.6	7	-25.3	-18.7	2.7
cash-flows.row.account-payables	0	-146.7	35.8	18.8	-251.4	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-2.2	-1.2	-10.9	18.2	131.4	63	-31.2	-27.9	56.7	-15.4	2.6	-44.3	-58.7	4.7	-7.2	-13.3
cash-flows.row.other-non-cash-items	39.32	210.7	-30.1	25.2	-48.2	142.1	-18.9	-15.9	11.3	51.2	27.1	12.5	11.3	4.6	8.7	6.4	2.5
cash-flows.row.net-cash-provided-by-operating-activities	31.18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-21.71	-40.7	-52.5	-62.1	-43.7	-44.8	-50.8	-78.1	-96.1	-133.9	-158.6	-181.5	-114.4	-25.5	-46.4	-28.3	-4.4
cash-flows.row.acquisitions-net	25.73	1.8	83.9	194.5	287.6	-1.8	72.7	102.7	-67.2	-128.9	-117.9	0	0	0	0	28.3	0
cash-flows.row.purchases-of-investments	-25.73	-116.4	-262.1	-543	-140.2	-169	-9.8	-196.7	-2	-26.1	-20.5	0	0	0	0	-31	0
cash-flows.row.sales-maturities-of-investments	4.07	54.7	228.4	33.9	117.3	11.8	2.6	135.8	14.4	29.4	2.7	0	0	0	0	31.4	0
cash-flows.row.other-investing-activites	0.92	0	3.5	7.1	29.5	64.1	5.8	-78.1	43.8	0.2	4.1	0.1	10.4	1.8	10.7	-28.3	0.1
cash-flows.row.net-cash-used-for-investing-activites	-6.23	-100.6	1.2	-369.6	250.5	-139.8	20.4	-114.5	-107	-259.3	-290.3	-181.3	-104	-23.7	-35.7	-27.9	-4.3
cash-flows.row.debt-repayment	-170.2	-232	-467	-130.7	-496	-1038.2	-356.1	-345	-298.6	-254	-203.5	-25	-32	-66.4	-38.6	-8	-8
cash-flows.row.common-stock-issued	0	3.1	22.7	29.5	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	-3.1	-22.7	-29.5	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-15.3	-11.9	-16.5	-46.6	-31	-45.1	-48.9	-68.1	-37.2	-37.5	-23.7	-11.9	-8.9	-7.3	-6	-0.7	-0.5
cash-flows.row.other-financing-activites	68.2	232.2	273.7	255.3	54	1118.2	310.4	436.7	298.3	150	812.8	149.7	12	420.3	76.3	60.2	8
cash-flows.row.net-cash-used-provided-by-financing-activities	-53.06	-11.8	-209.8	78	-473	35	-94.6	23.6	-37.5	-141.5	585.6	112.8	-28.9	346.6	31.8	51.5	-0.5
cash-flows.row.effect-of-forex-changes-on-cash	-3.24	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1	0
cash-flows.row.net-change-in-cash	-29.13	12	-63.2	-136.6	-143.4	216.2	47.2	-23.5	-11.4	-305.6	307.2	-43.5	-145.5	304.4	6.6	28.7	0.7
cash-flows.row.cash-at-end-of-period	255.13	57	45	108.3	244.8	388.3	172.1	124.8	148.3	159.7	465.2	158	201.5	347	42.6	36	7.3
cash-flows.row.cash-at-beginning-of-period	284.26	45	108.3	244.8	388.3	172.1	124.8	148.3	159.7	465.2	158	201.5	347	42.6	36	7.3	6.6
cash-flows.row.operating-cash-flow	31.18	124.3	145.4	155	79	321.1	121.4	67.4	133.1	95.3	11.9	25	-12.6	-18.5	10.5	5.2	5.4
cash-flows.row.capital-expenditure	-21.71	-40.7	-52.5	-62.1	-43.7	-44.8	-50.8	-78.1	-96.1	-133.9	-158.6	-181.5	-114.4	-25.5	-46.4	-28.3	-4.4
cash-flows.row.free-cash-flow	9.46	83.6	92.9	92.9	35.4	276.2	70.5	-10.7	37.1	-38.6	-146.7	-156.4	-127.1	-44	-35.9	-23.1	1.1

Kasumiaruande rida

Guangzheng Eye Hospital Group Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.401%. 002524.SZ brutokasum on teatatud 376.97. Ettevõtte tegevuskulud on 328.66, mille muutus võrreldes eelmise aastaga on 16.758%. Kulud amortisatsioonikulud on 100.02, mis on 0.003% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 328.66, mis näitab 16.758% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.929% kasvu võrreldes eelmise aastaga. Tegevustulu on 7.03, mis näitab -0.929% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -1.119%. Eelmise aasta puhaskasum oli 9.26.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008
income-statement-row.row.total-revenue	1058.07	1074.9	767.4	1044.5	921	1284.9	1175.3	554	499.3	555.2	626.3	505.4	465.8	426.4	381.7	276	237.7	154.2
income-statement-row.row.cost-of-revenue	689.43	697.9	575.9	709.2	606	800.7	831.4	453.5	408.1	364.8	535.3	423.1	398.7	366	330	230.6	196.2	131.4
income-statement-row.row.gross-profit	368.64	377	191.5	335.3	315	484.1	343.9	100.5	91.2	190.3	91	82.3	67.1	60.5	51.8	45.4	41.5	22.8
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	5.26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	37.86	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	191.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.04	0.9	104.7	89.4	89.2	109.7	-9.4	-1.5	10.9	28.7	8.7	23.6	16.6	7.1	3.8	1.8	-0.2	-0.2
income-statement-row.row.operating-expenses	337.23	328.7	281.5	334.3	276.5	309	243.1	95.9	100.1	160.8	115.5	61.2	32.4	29.8	24.1	17	12.8	8.4
income-statement-row.row.cost-and-expenses	1026.66	1026.6	857.4	1043.5	882.5	1109.8	1074.6	549.3	508.1	525.6	650.9	484.3	431.1	395.8	354.1	247.6	209	139.8
income-statement-row.row.interest-income	0.76	0.7	0.8	0.7	1.3	2	1.6	0.7	0.9	2.3	3.8	4.1	2.7	3.7	0.5	0.3	0.4	0.1
income-statement-row.row.interest-expense	39.08	38.8	36.3	37.7	26.4	31	42.7	32.1	36.6	30.2	37.6	27.8	8.3	4.4	3.9	1.5	0.7	0.5
income-statement-row.row.selling-and-marketing-expenses	191.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0.04	0.9	-174.2	-32.1	-50.7	-80.4	-132.6	11	22.5	-0.2	-39.4	-10.9	-1.4	-1.5	-0.2	-4.8	-4.7	-1.6
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.04	0.9	104.7	89.4	89.2	109.7	-9.4	-1.5	10.9	28.7	8.7	23.6	16.6	7.1	3.8	1.8	-0.2	-0.2
income-statement-row.row.total-operating-expenses	0.04	0.9	-174.2	-32.1	-50.7	-80.4	-132.6	11	22.5	-0.2	-39.4	-10.9	-1.4	-1.5	-0.2	-4.8	-4.7	-1.6
income-statement-row.row.interest-expense	39.08	38.8	36.3	37.7	26.4	31	42.7	32.1	36.6	30.2	37.6	27.8	8.3	4.4	3.9	1.5	0.7	0.5
income-statement-row.row.depreciation-and-amortization	40.76	100.3	100	106.4	62.6	98.4	98	84.2	81.8	77.3	55.1	28.3	14	8.6	6.2	3.3	2.4	1.6
income-statement-row.row.ebitda-caps	35.43	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-5.32	7	98.6	77	96.6	296.6	-22.5	17.1	4.8	1.2	-72.7	-13.4	22.5	23.2	23.7	21.8	24.2	13
income-statement-row.row.income-before-tax	-5.28	7.9	-75.6	44.9	46	216.2	-31.9	15.6	13.6	29.4	-64	10.3	33.2	29.2	27.5	23.6	24	12.8
income-statement-row.row.income-tax-expense	-3.23	-1.8	2.2	8.5	13.9	59.1	18.4	7.8	5.5	3.9	4.3	1.1	5.4	4.8	5.2	4.5	1.7	0.9
income-statement-row.row.net-income	-1.62	9.3	-77.8	36.9	32.1	157.1	-74.8	5.4	4.8	6.5	-87.7	1.5	27.9	24.3	22.3	19.1	22.4	11.9